Back to calendar
Xilio Therapeutics, Inc. (XLO) Earnings
XLO reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Est. EPS: $-0.94
Actual EPS: $-0.33
EPS surprise: 44.07%
Company overview
Market Cap$52.5M
PriceUSD 7.97
EPS (TTM)-1.69
52-week high12.58
52-week low6.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees76